{"entity":{"id":"ucb","kind":"company","name":"UCB","aka":["UCB Biopharma SRL","UCB Pharma","UCB S.A."],"tldr":"UCB is a Brussels pharmaceutical company focused on neurology and immunology whose cancer trials on the registry are mostly older programmes and supportive care studies.","summary":"UCB is a Belgian biopharmaceutical company, listed on Euronext Brussels, whose marketed medicines are in epilepsy, immunology and rare diseases. Its subsidiaries UCB Biopharma SRL and UCB Pharma appear as lead sponsors of a number of phase 3 cancer trials on ClinicalTrials.gov, largely from earlier programmes and studies of supportive medicines; oncology is not part of its current core strategy. OnCo records it so that those trials resolve to a sponsor page.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.ucb.com"},{"label":"ClinicalTrials.gov: trials led by UCB","url":"https://clinicaltrials.gov/search?lead=UCB"},{"label":"Wikipedia","url":"https://en.wikipedia.org/wiki/UCB_(company)"}],"tags":["ctgov-sponsor"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Brussels","country":"BE","companyType":"pharma","website":"https://www.ucb.com","stage":"public","investors":[],"funding":[]},"route":"/companies/ucb/","neighbours":{}}